HDL as a treatment target†

Journal of Clinical Lipidology

Volumn 4, Issue 1, 2010, Pages 5-16

  Brown, W Virgil ^a   Brewer, H Bryan ^b   Rader, Daniel J ^c   Schaefer, Ernst J ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; C REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPASE A2; VERY LOW DENSITY LIPOPROTEIN;

CARDIOVASCULAR DISEASE; CHOLESTEROL TRANSPORT; INNATE IMMUNITY; ISCHEMIC HEART DISEASE; LIPID OXIDATION; LIPOPROTEIN METABOLISM; METABOLIC DISORDER; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CHOLESTEROL ESTER TRANSFER PROTEINS; HUMANS; HYPERLIPOPROTEINEMIAS; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, HDL; MICE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 75749146275     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2009.12.005     Document Type: Review

References (0)